Gunnar Cario
Alemtuzumab treatment for steroid-refractory acute graft-versus-host disease leads to severe immunosuppression but not to relapse of malignant disease.
Philippen L, Schub N, Günther A, Cario G, Schrappe M, Repp R, Gramatzki M. Alemtuzumab treatment for steroid-refractory acute graft-versus-host disease leads to severe immunosuppression but not to relapse of malignant disease. Bone Marrow Transplant 2023; 59:153-155.
06.11.2023Alemtuzumab treatment for steroid-refractory acute graft-versus-host disease leads to severe immunosuppression but not to relapse of malignant disease.
06.11.2023Bone Marrow Transplant 2023; 59:153-155
Philippen Lennart, Schub Natalie, Günther Andreas, Cario Gunnar, Schrappe Martin, Repp Roland, Gramatzki Martin
MondoA Drives B-ALL Malignancy through Enhanced Adaptation to Metabolic Stress
Sipol A, Thiel U, Görlach A, Cario G, Brenner D, Richter G, Grünewald T, Rad R, Wolf E, Ruland J, Sorensen P, Schmäh J, Petry A, Hameister E, Xue B, Hofstetter J, Barenboim M, Öllinger R, Jain G, Prexler C, Rubio R, Baldauf M, Franchina D, Burdach S. MondoA Drives B-ALL Malignancy through Enhanced Adaptation to Metabolic Stress. Blood 2021
28.04.2021MondoA Drives B-ALL Malignancy through Enhanced Adaptation to Metabolic Stress
28.04.2021Blood 2021
Sipol Alexandra, Thiel Uwe, Görlach Agnes, Cario Gunnar, Brenner Dirk, Richter Günther, Grünewald Thomas G P, Rad Roland, Wolf Elmar, Ruland Jürgen, Sorensen Poul H, Schmäh Juliane, Petry Andreas, Hameister Erik, Xue Busheng, Hofstetter Julia, Barenboim Maxim, Öllinger Rupert, Jain Gaurav, Prexler Carolin, Rubio Rebeca Alba, Baldauf Michaela, Franchina Davide G, Burdach Stefan E G